Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS
0 Lượt xem
• 07/16/23
0
0
Nhúng
administrator
Người đăng ký
Visit http://www.ecancer.org for more
Prof Margolese (The Jewish General Hospital, McGill University, Montreal, Canada) presents, at a press conference at ASCO 2015, a federally funded phase III trial suggests that postmenopausal women with ductal carcinoma in situ (DCIS) may have an additional option for breast cancer prevention.
Cho xem nhiều hơn
Bình luận trên Facebook
SORT BY-
Nhận xét hàng đầu
-
Bình luận mới nhất